A deep investigation into peptide scams to skip vendors that will rob your money, waste your research, or get raided.
A genuine lab certificate isn’t always evidence of what’s inside a vial.
We also investigated the shady laboratories handing out certificates.
A CoA doesn’t mean a vial is safe or correctly labeled.
There are two ways your money can go up in smoke in this market. Fraud. And from a vendor who goes heave-ho a week after your order ships.
Is That Peptide Vendor Legit? Confirmed Scams to Avoid
Peptide vendor
watchlist.
Two evidence tiers: government-documented actions, and separately labeled reports or unresolved certificate questions. A source explaining a test does not authenticate a vendor’s report.
Paradigm Peptides
Owner sentenced to federal prison. DOJ documented fraudulent quality claims and mislabeled products.
Figures from DOJ announcement and contemporaneous reporting
Read the record
According to the U.S. Department of Justice, Matthew Kawa and Jennifer Stechkober pleaded guilty to selling unapproved drugs with intent to defraud and mislead. Kawa was sentenced to 70 months, Stechkober to 16 months; a $5 million money judgment and $78,317.52 restitution were entered. DOJ says the business falsely claimed its products were manufactured and quality-tested in its own U.S. laboratories, while it imported products from Asia and did not test them before sale. DOJ reports that multiple SARMs products contained testosterone instead. The DOJ release supports false testing claims; it does not independently substantiate this card’s former allegation of forged COA documents.
Primary recordU.S. Department of Justice · July 30, 2026 sentencing release
Amino Asylum
Reported website closure; alleged FDA raid not independently substantiated.
Reported enforcement action · Verify current status independently
Read the record
The original submission alleges that Amino Asylum went offline in June 2025 after FDA action and that copycat websites subsequently appeared. We could not find a direct FDA or DOJ document supporting a raid, an official closure order, or an authenticated successor domain. This entry is retained only as an unverified closure report, not documented federal enforcement.
No case-specific FDA or DOJ record verified. Do not describe a raid as established.
Tailor Made Compounding
DOJ documents a guilty plea and sentencing for unlawful distribution of unapproved drugs, including BPC-157.
Figures from DOJ case reporting
Read the record
DOJ reports that Tailor Made Compounding pleaded guilty in October 2020 to distributing unapproved drugs, including BPC-157, and was sentenced in February 2021 to three years of probation and forfeiture of $1,788,906.82. Its owner pleaded guilty to a different charge concerning unlicensed wholesale distribution of a prescription drug. These are historical case outcomes, not evidence of the present-day status of a similarly named business.
Primary recordDOJ · February 24, 2021 sentencing release
FDA Letters · Dec 2024
Four vendors cited for selling GLP-1 peptides as unapproved drugs.
Four companies confirmed in FDA’s December 17, 2024 roundup
Read the record
FDA announced four warning letters involving Xcel Peptides (Xcel Research LLC), Swisschems, Summit Research and Prime Peptides (Prime Vitality, Inc.) over marketing unapproved GLP-1 products. A separate letter to Veronvy was also announced, but it is not counted among these four peptide sellers. Each letter is a documented agency notice, not a criminal conviction or proof of present-day noncompliance.
Primary recordFDA · December 17, 2024 roundup
ITC Orders · Apr 2025
U.S. International Trade Commission orders; check each named party and remedy.
Orders published on the USITC docket
Read the record
USITC investigation 337-1377 lists cease-and-desist orders for Arctic Peptides LLC, Strate Labs LLC and Triggered Supplements LLC, plus limited exclusion orders concerning entities including Super Human Store and AustroPeptide. Its docket shows the Commission issued the orders on April 9, 2025, not January. Scope and effect differ by respondent and order; the docket does not establish any buyer’s entitlement to refunds or the outcome of a particular package.
Primary docketUSITC · investigation 337-1377 and order status
USA Peptide
FDA warning letter over unapproved and misbranded GLP-1 peptides.
FDA warning letter 696885 · issued Feb 26, 2025
Read the record
FDA’s letter 696885 states that usapeptide.com offered unapproved and misbranded semaglutide and tirzepatide to U.S. consumers. FDA explained why “research use only” labeling did not override other evidence of intended human use. This notice is an agency finding, not a criminal verdict.
Primary recordFDA · USApeptide.com warning letter 696885
Pinnacle Peptides
Warning letter issued after the FDA reviewed the company website.
Letter published in the FDA warning letter database
Read the record
FDA issued warning letter 719337 on December 12, 2025 to Pinnacle Professional Research, doing business as Pinnacle Peptides. Its specific cited products were SARMs, including S4 Andarine, LGD-4033 and MK-2866, rather than a confirmed peptide-quality or GLP-1 laboratory finding. FDA’s website review occurred in November 2025.
Primary recordFDA · Pinnacle Peptides warning letter 719337
FDA Sweep · Sept 2026
Five FDA warning letters dated August 24, 2026; Peptide Partners documented individually below.
Letters dated 24 August 2026 · Published in the FDA database
Read the record
FDA issued warning letters dated August 24, 2026 to Peak Performance Peptides, Royal Peptides LLC, NuScience Peptides LLC, Peptide Partners LLC and TXP Innovations LLC (Tex Peptides). Its Peptide Partners letter 735063 specifically names GLP-1 S (semaglutide), GLP-2 T (tirzepatide), GLP-3 Reta (retatrutide), SS-31, tesamorelin, PT-141 and reconstitution solution as unapproved drugs as marketed. FDA says research-use-only language did not override other evidence of intended human use, and sales of reconstitution solution alongside injectable products supported that assessment. Warning letters do not establish individual lot purity or criminal guilt.
FDA original lettersPeptide Partners · 735063 · Peak Performance · 735127 · NuScience · 733652
Peptide Sciences
Reported closure; no company-specific enforcement record established here.
Reported figures · Company stated the closure was voluntary
Read the record
The submitted material reports a closure notice described by the company as voluntary. We did not verify its claimed monthly revenue or establish an FDA, DOJ or ITC action against this specific company. Do not infer that a broader period of regulatory activity caused its closure.
No company-specific government enforcement document verified. Closure and revenue claims need contemporaneous independent evidence.
JEEP
Reported endotoxin finding in orange-cap T30 vials.
Figures from the submitted draft · Not independently verified
Read submitted report
Orange-cap Tirzepatide “T30” failed endotoxin testing across three vials from three countries. No recall issued. Purity numbers were clean, which is the trap: a purity COA does not test endotoxin unless someone pays separately.
No supporting source link was included with this entry.
XTP
Reported mismatch between the labeled and tested compound.
Figures from the submitted draft · Not independently verified
Read submitted report
Sold a batch labeled 30mg retatrutide that tested as roughly 2mg of tirzepatide. Wrong drug, wrong dose. XTP commissioned and paid for the re-test themselves.
No supporting source link was included with this entry.
Coastal Peptides
Reported semaglutide / cagrilintide identity mismatch.
Figures from the submitted draft · Not independently verified
Read submitted report
Sold “semaglutide” that was actually cagrilintide, an entirely different peptide. One budget lab initially missed it and had to issue corrected certificates, which tells you something about cheap testing too.
No supporting source link was included with this entry.
PeptiLab
Reports concerning peptide content and bacteriostatic water.
Figures from the submitted draft · Not independently verified
Read submitted report
Testing revealed no active peptide whatsoever. Their bacteriostatic water was also reported contaminated with mold. A nightmare scenario in a single vendor.
No supporting source link was included with this entry.
Phoenix Labs
Buyer allegations concerning contamination and impurities.
Read submitted report
Buyer reports of severe contamination and impurities.
No supporting source link was included with this entry.
Modern Peptides
Allegation that laboratory certificates were fabricated.
Read submitted report
Forged Janoshik certificates for tests that never happened. The scary part: automated trust scanners rated the domain “safe” while the community had already caught the forgery. Do not outsource your judgment to a trust badge.
No supporting source link was included with this entry.
Simple Peptides
Questions concerning analysis reports and company history.
Read submitted report
Inconsistent chemical analysis reports and questionable launch-date claims. A common signature of a fresh scam wearing the mask of an established brand.
No supporting source link was included with this entry.
QSC (“Tracy”)
Reports of interrupted service, unresolved orders and a forum ban.
Figures from the submitted draft · Not independently verified
Read submitted report
Went dark December 2024. Returned August 2025 with a story about arrests and no refunds. Went dark again March 2026 on nearly the same script. MESO-Rx permanently banned them in June 2026, not for the shipping disputes but for doxxing a complaining customer.
No supporting source link was included with this entry.
Peptide University
Reported group-buy collapse and customer losses.
Figures from the submitted draft · Not independently verified
Read submitted report
A group-buy that collapsed in July 2026, with funds traced to crypto exchanges.
No supporting source link was included with this entry.
Top Peptides
Report of an unavailable website and email-only ordering.
Read submitted report
Domain down. Email-only sales. When the website disappears and the only way to buy is by email, walk away.
No supporting source link was included with this entry.
Prime Peptides
Reports concerning unfulfilled orders. Also an FDA warning letter recipient.
Read submitted report
Unfulfilled-order complaints in the original draft were not independently authenticated and are not findings. Separately, the FDA issued warning letter 695156 to Prime Vitality, Inc., doing business as Prime Peptides, on December 10, 2024 concerning marketed semaglutide and retatrutide. The order complaint and FDA letter are two distinct types of evidence.
Confirmed regulation onlyFDA · Prime Peptides warning letter 695156
Changan Sheng Peptides
Questions concerning shipping origin and customs seizures.
Read submitted report
Operates mainly through Telegram, takes Bitcoin, advertises US shipping. Actually ships from Hong Kong. Customs seizures reported by buyers.
No supporting source link was included with this entry.
The Serial Chain
Alleged links between three successive seller names.
Read submitted report
PremiumPeptideCo → ResearchChemDirect → PeptideElite. Each vanished within months of the last, linked by shared promo accounts and payment rails. Assume the next name is the same operation.
No supporting source link was included with this entry.
Silent Deaths of 2025
Reports of four sellers going offline with open orders.
Read submitted report
Royal Research · Peptide Tech Labs · American Research Labs · Unchained Compounds. All went offline during 2025 with no notice to customers holding open orders.
No supporting source link was included with this entry.
Optima Supply
5-Amino-1MQ certificate: reported content and chemistry inconsistencies.
Certificate figures are transcribed from the submitted research dossier, not independently authenticated.
Read the document questions
The submitted dossier describes Chromate report #32565 for a 5-Amino-1MQ vial labeled 25 mg. It reports 83.28 mg, uses conflicting iodide-salt versus cation chemistry information, and calls a small molecule a peptide. PubChem independently identifies the iodide salt as 286.11 g/mol; the salt/cation mass ratio alone does not resolve the apparent 3.33× difference. Without the original lab record and the defined label/assay mass basis, the cause cannot be determined. This is NOT an authenticated finding that the vial actually contains 83.28 mg, that the COA is forged, or that the vendor committed fraud.
Source gap: original COA #32565 is described in a submitted research dossier, but its issuing laboratory has not confirmed this report. The PubChem link establishes chemistry only; it does not authenticate Optima’s certificate.
Independent context — not COA authenticationNIH PubChem · 5-Amino-1MQ iodide chemistry
Red Fox Peptides
Blend COA gives an insufficiently explained combined purity and endotoxin result.
Certificate figures are transcribed from the submitted research dossier, not independently authenticated.
Read the document questions
The submitted dossier describes a Testides certificate for a GHK-Cu, BPC-157, TB-500 and KPV blend. It reports a combined 99.92% purity without explaining how each component and impurity are accounted for. It also describes an endotoxin result below 0.125 EU/mL with a 1:16 dilution but does not clarify whether the reported value was dilution-corrected or show the maximum-valid-dilution calculation. A combined mixture metric could be meaningful if properly defined; this report’s basis requires clarification. FDA guidance explains the significance of method suitability, product interference and dilution limits. No actual endotoxin failure or certificate fabrication has been established.
Source gap: this FDA guidance covers methods in general. It does not document Red Fox, confirm the lab report, or establish that this particular sample failed.
Independent context — not COA authenticationFDA · March 2026 endotoxin testing guidance
Licensed Peptides
Product’s LCMS claim is not substantiated by the specific HPLC-only report reviewed.
Certificate figures are transcribed from the submitted research dossier, not independently authenticated.
Read the document questions
The submitted dossier describes an Ethos Analytics report for a 50 mg capsule reporting 52.59 mg using HPLC. The product bottle reportedly claims LCMS testing, but this specific report does not provide LC-MS evidence. Ethos cites ISO/IEC 17025 credentials; whether this exact 5-Amino-1MQ method is covered by a current published accreditation scope has not been independently established. Being a laboratory that also tests hemp or cannabis does not invalidate a chemical assay. A separate LC-MS report or scope document could resolve the omissions. No fabricated COA, false accreditation or unsafe product has been established.
Source gap: no independent public copy of report 26EA0318-044 or relevant accrediting-body scope has been authenticated. The NIST link explains accreditation, not allegations about this vendor.
Independent context — not COA authenticationNIST · how laboratory accreditation works
aiopeptides.co
BBB Scam Tracker user alleges extra shipping charges and non-delivery at a lookalike domain.
BBB Scam Tracker information comes from a complainant’s submitted account; it is not an adjudicated finding.
Read the complaint
A customer-submitted BBB Scam Tracker report dated June 30, 2026 identifies aiopeptides.co and alleges that a site resembling another business accepted payment, demanded additional shipping money, and then stopped responding after a refund request. The complainant reports $260 lost. BBB publishes consumer-submitted accounts and does not adjudicate fraud in this report. This is a complaint about the .co address ONLY. It must not be attributed to the separate aiopeptides.com vendor without evidence linking the operators.
BBB reproduces the complainant’s account. The complaint and the .co/.com ownership relationship were not independently adjudicated.
Original customer complaint — allegations unverifiedBBB Scam Tracker · original complaint 1339510
NextGenPeps (nextgenpeps.com)
Trust-scanner and consumer-review flags point to delivery/payment risk and lookalike confusion; no government enforcement record was established in this review.
Scanner and review figures are third-party snapshots; they are not adjudicated fraud findings.
Read the record
nextgenpeps.com markets itself as a research-peptide storefront and says products are tested by Janoshik or BioRegen. Independent review captures show a small, mixed Trustpilot footprint: one Trustpilot page showed 3.4/5 across 23 reviews, while an independent review article cited a lower 2.6 score and active scam reports. Gridinsoft’s URL scanner assigned the domain a 1/100 trust score and categorized reports as “payment accepted first, delivery issues later.” Because the site name is close to other “Next Gen” peptide domains, reviewers also warn buyers not to transfer trust from one domain to another. This entry records third-party risk signals only. No FDA warning letter, DOJ case, or ITC order naming nextgenpeps.com was found in the records checked for this update.
Source gap: trust scanners and review sites aggregate consumer reports; they do not prove a particular order was fraudulent. Ratings and scanner scores can change. Verify the current domain, batch COA, and company identity before relying on this card.
Public records checkedTrustpilot · nextgenpeps.com review page · Gridinsoft · nextgenpeps.com scan · Peptides Explorer · NextGen Peptides review context · nextgenpeps.com · vendor homepage claims
I’ve spent years watching this industry.
Three Questions to Ask About a CoA
Who selected the sample?
A vendor might submit one vial from a large batch.
The laboratory can report the results for that sample, but it cannot automatically establish that every vial in the batch has the same contents.
A genuine certificate doesn’t prove that the sample was randomly selected or independently purchased.
Vendor-submitted testing, independent mystery-shopping and documented random sampling offer different levels of evidence about the wider product supply.
Did the laboratory use the right test?
A laboratory may accurately perform an HPLC analysis that answers a narrow question.
That analysis may still be insufficient to establish molecular identity, net content or contamination levels.
Even ISO-accredited laboratories can perform tests outside their accredited scope.
You have to check the method, material and claimed measurement—not just the laboratory’s logo.
Are you seeing every test?
Vendors generally control which reports they publish.
A vendor could commission several tests and publish only favorable results.
And I show you exactly which vendors are legit trash. Which ones got taken down so you won’t be fooled by copycats. And a couple of red flags that expose a fake peptide vendor before you sneak out your credit card from that thick wallet.
Let me save you the cash from peptide scams I paid to learn this.
Why Fake Peptides Are Worse Than a Waste of Money
A fake peptide isn’t only expensive water. That’s almost a good outcome.
A 2018 analysis of falsified peptide drugs had purity as low as 5%. The lead concentrations show ten times above safety limits. You buy lead, mystery compounds, and a vial that contains something else entirely than what it says.
I’ve seen researchers order BPC-157 and receive GHRP-2. I’ve seen Photoshopped Certificates of Analysis. The whole market runs on trust. Trust is so easy to fake, it isn’t funny anymore. There’s no regulator checking the work.
That’s the part people miss. Underdosed peptides destroy your research before you even know what went wrong. You follow a protocol and get nothing. You blame the compound. The real problem was the shady vendor.
Fake vs Real Peptides: Underdosing, Contamination and Counterfeits
A wack vendor falls into one of two buckets.
Outright scam. Fake COAs. Contaminated peptides. Exit scams when your money vanishes before you realize what happened. These are reported by real people, community profiles, and lab tests that flagged compounds as dangerous.
Shutdown risk. Not always scams. Some sold legit products. But they crossed a regulatory line and attracted federal attention, then disappeared. Your money disappears as well, whether the vendor was a crook or a casualty.
Both types of scams cost you. Here are the names in each.
Peptide Vendors Shut Down or Raided in 2025 and 2026
This is the part most “scam” lists ignore, and it’s the bigger story of 2026.
Amino Asylum. Raided by the FDA in June 2025. Site permanently gone within days. Before the raid, they clocked an estimated 400,000 monthly visitors and ranked in the top five most-searched peptide vendors in the country. Reports point to ignored warning letters. Marketing that blurred research chemicals into consumer health claims. And selling prescription-only medications. Sites keep spawning under names like aminoasylum.us and aminoasylums.shop. None are verified. Do not order from any of them. They might ride on the name to get found easily online by searchers.
Peptide Sciences. The big mac. The largest grey-market peptide vendor in the United States, doing a reported $7.4 million a month, posted a three-sentence notice and went radio-silent. Voluntary, they said. The timing tells a different story. It landed in the middle of the most aggressive enforcement period the industry has ever witnessed. Reporting tied it to FDA pressure, pharmaceutical litigation over GLP-1 copies. And failed third-party tests on Retatrutide.
Tailor Made Compounding. Prosecuted by the Department of Justice for distributing unapproved peptides including BPC-157. Forced to forfeit $1.79 million. This is the one that should make you sit up straight because it was criminal, not administrative.
The warning-letter list. In late 2024 the FDA sent letters directly to:
- Prime Peptides
- Xcel Peptides
- SwissChems
- Summit Research
A warning letter is not a death sentence. But it tells us which vendors are working in the agency’s crosshairs.
At least seven other research peptide companies closed during 2025 alone. The “research use only” label that the whole market hides behind is no longer the legal shield it once was.
How to Spot a Fake Peptide Vendor Before You Pay
You don’t have to be a chemist and know the list of peptides by heart. A checklist and ten minutes will do. Learn these red flags that catch most bad actors before they catch you.
Sells injection kits. Bacteriostatic water, syringes, alcohol swabs, dosing calculators. A vendor genuinely selling to laboratories doesn’t need to bundle the supplies for human administration. The FDA has cited exactly this in its letters, and it’s one of the fastest ways a site hands over its own intent.
No batch-specific COA. Retreat if there’s no Certificate of Analysis. And even if it’s only “available on request,” or doesn’t match the lot number on your vial. A real vendor links a batch COA right on the product page.
A perfect 99.9% purity on everything. Sounds backwards? Real HPLC testing produces variation. Honest numbers land around 98 to 99.2% and move batch to batch. A flawless score across every product is fabricated.
Crypto or gift cards only. Payment processors avoid peptide sellers. Card acceptance is therefore a genuine trust signal. And it offers you chargeback protection. Gift-card-only checkout is a remarkable scam.
Prices more than 50% below market. If everyone sells a compound for $60 and one vendor lists it at $20, they are either cutting the product or running a loss-leader exit scam. Neither helps you.
A domain younger than six months. Fresh domains with established-brand names are classic frauds. Check the site age before you trust the storefront.
Health claims or human-dosing instructions. The one This is the one that gets vendors raided. A site making therapeutic claims is telling you it does not understand or respect the line it is standing on. A candidate for the next blackout.
Recycled chemist signatures. If the same signature shows up on COAs across supposedly different labs, the documents are a hoax.
I built a full breakdown of how we score every vendor against these factors in our vendor testing methodology. If you want the system instead of the summary, that is where it lives.
What to Do If Your Vendor Just Got Shut Down
If you ordered from a vendor that went dark, move fast.
File a chargeback with your card immediately if the order hasn’t shipped. This is why card payments matter. Crypto buyers have no say here.
Don’t chase successor sites. When a raided brand shows up under a slightly different domain, it’s either opportunists living on the name or the same operation trying to dodge the heat. Neither is safe.
Then move to a vendor that survives the checklist above. We keep a current list of the legit peptide vendors that still pass third-party COA verification, and it is updated as the market shifts.
Legit Peptide Companies: How to Choose After the Shakeout
The peptide market in 2026 is a minefield. Scammers who never had peptides delivered, and real vendors who got too big or too loud and got raided.
Check out our top 10 trusted peptide vendors if you want to learn more.
The defense is the same. Demand a batch-specific COA. Verify the lab. Pay by card. Avoid the names on this page and the patterns I told you about. A vendor that can’t make it in that ten-minute checklist hasn’t earned your trust. No matter how good the price seems.
Get this part right and the rest of your research stands a solid chance. Get it wrong and you’re using lead-laced powder with a rigged certificate.
Choose the vendor like your results depend on it. They do.
Disclaimer: All peptides discussed are for in-vitro laboratory research purposes only and are not for human consumption. This article reports publicly documented enforcement actions and community-sourced accounts for informational purposes and does not constitute legal, medical, or purchasing advice. Vendor statuses change; verify current information independently before making any decision.
